US 7,842,459 B2 · Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

AssigneeCompugen Ltd.

InventorsMichal Ayalon-Soffer, Sarah Pollock, Ronen Shemesh, Rotem Sorek, Zurit Levine, Zipi Shaqed, Amir Toporik, Gad S. Cojocaru, Dvir Dahary, Guy Kol, Pinchas Akiva, Amit Novik, Sergey Nemzer, Alexander Diber, Maxim Shklar, Osnat Sella-Tavor, Lily Bazak, Ariel Farkash, Yossi Cohen

Life of this patent

Estimating the term…

Abstract

Novel splice variant nucleic acid sequences. The novel splice variants and their nucleic acid sequences according to the present invention may optionally be used for diagnosis of a variant-detectable disease as described herein.

Claims5

Dependent claims

An isolated polynucleotide consisting of the sequence selected from the group consisting of SEQ ID NOs 869, and 876 or a polynucleotide at least 95% identical thereto.

Dependencies are inferred from the claim text.

Facts

Application

11/051,646Filed 27 Jan 2005 · us provisional application

Priority

27 Jan 2004

Published

US 2010/0120022 A113 May 2010

Granted

30 Nov 2010

Term ends

Not estimatedThe source records don’t support an estimate.

Classification3 codes

C12Q 1/6886
For diseases caused by alterations of genetic material: for cancer
C12Q 2600/156
Oligonucleotides characterized by their use: polymorphic or mutational markers
C12Q
Measuring or testing processes involving enzymes, nucleic acids or microorganisms

Family

Application60/539,129Us provisional application · filed 27 Jan 2004

Application60/539,128Us provisional application · filed 27 Jan 2004

Application60/628,666Us provisional application · filed 18 Nov 2004

US 2010/0120022 A1Pre-grant publication · published 13 May 2010

US 7,842,459 B2This patent

From the US filing history. Foreign family members aren’t listed.